Polycystic Kidney Disease (Discovered in the Bull Terrier)
Polycystic Kidney Disease (Discovered in the Bull Terrier). Autosomal dominant. Observed in 2 of 266 breeds tested in the Sniff Atlas, with measured at-risk genotype frequencies drawn from 242,624 dogs (Donner 2023). Because this is a dominant trait, a single copy places a dog at risk rather than making it a silent carrier; whether the phenotype appears still depends on penetrance, modifier genes, and environment.
Dominant trait. A single copy of this variant places a dog at risk; it does not make the dog a silent carrier. The breed frequencies below are therefore at-risk frequencies, and penetrance plus modifier genes determine whether the phenotype actually appears.
- OMIA identifier
- OMIA:000807-9615
- InheritanceInheritance patternWhat it isHow the condition is passed down: recessive (two copies needed), dominant (one copy), or more complex.For your dogRecessive means a single-copy carrier is usually healthy but can still pass it on.PreciselyThe documented mode of Mendelian transmission (autosomal recessive or dominant, X-linked, etc.) per OMIA.OMIA · documented
- Autosomal dominant
- Source dataset
- Sniff Atlas v1.0.1 / DOI
A model of human polycystic kidney disease 1
This is the canine counterpart of polycystic kidney disease 1 in people. That makes affected dogs a naturally-occurring model of the human disease, and it is part of why studying dogs moves medicine forward for everyone. It does not mean your dog has the human disease. It means the two share an underlying biology.
In people, the disease is described as: Any autosomal dominant polycystic kidney disease in which the cause of the disease is a mutation in the PKD1 gene.
In humans it is also called: APKD1, PKD1, polycystic kidney disease type 1, Potter type 3 polycystic kidney disease.
Mapped from OMIA via the human disease's OMIM entry to the Mondo Disease Ontology (Monarch Initiative, CC-BY 4.0). Sniff renders this as a model-of link; the canine disease remains the subject of this page.
From OMIA's curated record
Documented in OMIA (Online Mendelian Inheritance in Animals). This describes the disease as recorded in the published literature, not a prediction for any individual dog. As of 2026-06-03.
Summary
Clinical features
Molecular genetics
Pathology
Human analog
OMIA links this condition to its human counterpart in OMIM (Mendelian Inheritance in Man), the place to read across to the deeper human literature for the same biology.
Source: OMIA (Nicholas, Tammen & the Sydney Informatics Hub), entry OMIA:000807-9615, doi:10.25910/2AMR-PV70 (CC-BY 4.0).
How it presents
Catalogued in the Mondo disease ontology (the cross-species disease identity used by the Monarch Initiative) as polycystic kidney disease 1 (MONDO:0008263).
Phenotype terms: Human Phenotype Ontology + Mammalian Phenotype Ontology; disease terms: Mondo (Monarch Initiative). Cross-references curated by OMIA (doi:10.25910/2AMR-PV70, CC-BY 4.0).
Published references
The peer-reviewed papers behind this disease, curated by OMIA. Starred entries are OMIA-designated landmark papers. Showing 6 of 19.
- Cross-species insights into autosomal dominant polycystic kidney disease: Provide an alternative view on research advancement. · Int J Mol Sci · 2024 · PMID 38891834
- PKD1 nonsense variant in a Lagotto Romagnolo family with polycystic kidney disease. · Genes (Basel) · 2023 · PMID 37372390
- An overview of in vivo and in vitro models for autosomal dominant polycystic kidney disease: A journey from 3D-cysts to mini-pigs. · Int J Mol Sci · 2020 · PMID 32630605
- A non-synonymous mutation in the canine Pkd1 gene is associated with autosomal dominant polycystic kidney disease in Bull Terriers. · PLoS One · 2011 · PMID 21818326
- Linkage confirms canine pkd1 orthologue as a candidate for bull terrier polycystic kidney disease. · Anim Genet · 2009 · PMID 19397527
- Linkage analysis excludes the involvement of the canine PKD2 homologue in bull terrier polycystic kidney disease. · Anim Genet · 2006 · PMID 16978192
References curated by OMIA (Nicholas, Tammen & the Sydney Informatics Hub), doi:10.25910/2AMR-PV70 (CC-BY 4.0). Full list at the OMIA entry.
Set each parent's status for Polycystic Kidney Disease (Discovered in the Bull Terrier) and see the odds for their puppies. Single dominant variant, exact Mendelian math.
These are the genetic odds for one known variant, not a promise: a real litter varies around them, and penetrance or other genes can change whether the condition ever appears. Use it to avoid pairing two carriers and to keep a line healthy, not to engineer a dog. Inheritance mode per OMIA.
See what Polycystic Kidney Disease (Discovered in the Bull Terrier) looks like in your dog's breed.
Top 2 well-sampled breeds (n ≥ 50)
Maximum at-risk frequency per breed across variants in the Donner 2023 cohort, with Wilson 95% confidence intervalsWilson 95% confidence intervalWhat it isThe range the true frequency is probably in. A wide range means we are less sure, usually because few dogs were tested.For your dogTrust tight ranges; treat wide ones as rough estimates.PreciselyA binomial-proportion confidence interval (Wilson score, 95%) that stays reliable at small sample sizes.Sniff Atlas methodology · statistical. The list below is split into well-sampled breeds (n ≥ 50 tested) and small-sample breeds (n < 50, where the Wilson CI typically spans more than 20 percentage points and frequencies should not be compared directly to the well-sampled entries). Frequencies are population-level, not per-litter or per-line.
▸ Full table with Wilson 95% confidence intervals
| Breed | At-risk frequency | n tested |
|---|---|---|
| Labrador Retriever | <0.1% | 16,856 |
| American Staffordshire Terrier | <0.1% | 42,786 |
264 additional breeds in the Donner 2023 cohort were tested but showed no at-risk genotypes.
From genotype to phenotype
For this dominant trait, a dog with even one copy is at risk, not a silent carrier. Penetrance is the fraction of at-risk dogs that actually develop the phenotype. The Donner 2023 S4 table tracks this for 1 variant(s) underlying this disease in the cohort.
- At-risk dogs evaluated
- 1
- Phenotype confirmed
- 0
- Penetrance range
- not yet quantifiable
Fewer than 20 at-risk dogs evaluated; too few to state a penetrance figure.
Predicted disease relevance at the per-dog level is UNPROVEN. The at-risk frequency is measured; phenotype outcome is governed by penetrance, environment, and modifier loci. Consult a veterinarian for clinical interpretation.
Citations
If you use this record in published work, cite the Sniff Atlas (the published dataset that carries the breed-level carrier frequencies) and the upstream sources:
- Sniff Atlas v1.0.1 for the per-breed carrier frequencies:
Gehring, M. (2026). Sniff Atlas v1.0.1. Zenodo. https://doi.org/10.5281/zenodo.20566358. CC-BY 4.0.
- OMIA for the disease definition, inheritance, and gene assignment:
Nicholas, F. W., & Tammen, I. (2024). OMIA. Sydney Informatics Hub, The University of Sydney. https://doi.org/10.25910/2AMR-PV70. Entry: OMIA:000807-9615.
- Donner et al. 2023 for the breed × variant carrier-frequency cohort:
Donner, J., Freyer, J., Davison, S., Anderson, H., Blades, M., Honkanen, L., et al. (2023). Genetic prevalence and clinical relevance of canine Mendelian disease variants in over one million dogs. PLOS Genetics, 19(2), e1010651. https://doi.org/10.1371/journal.pgen.1010651.
Full citation formats (BibTeX, RIS, CITATION.cff) at sniff.world/cite.
Related
- Sniff Atlas v1.0.1, the source dataset for these frequencies.
- Browse breeds, per-breed Mendelian profiles, including this disease in context.
- OMIA entry OMIA:000807-9615, authoritative clinical reference.
- About OMIA, the catalogue this record comes from, and how Sniff uses it.